KYLE JONES: Open Payments
NPI 1386179257 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 19 payments from 5 companies in 2025. Trend: 2023 $352 · 2024 $651 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $256 |
| Abbott Laboratories | 3 | $146 |
| Gilead Sciences, Inc. | 4 | $96 |
| Merck Sharp & Dohme LLC | 4 | $88 |
| Verity Pharmaceuticals Inc. | 3 | $48 |
Products named: FREESTYLE LIBRE 3, Ozempic, Wegovy, PIFELTRO, Tlando, CAPVAXIVE.
Industry payments across GA — which companies pay providers there.
